Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein array.

Broutin S, Commo F, De Koning L, Marty-Prouvost B, Lacroix L, Talbot M, Caillou B, Dubois T, Ryan AJ, Dupuy C, Schlumberger M, Bidart JM.

Thyroid. 2014 Jan;24(1):43-51. doi: 10.1089/thy.2013.0514. Epub 2013 Dec 24.

PMID:
24256343
2.

Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein array.

Broutin S, Commo F, De Koning L, Marty-Prouvost B, Lacroix L, Talbot M, Caillou B, Dubois T, Ryan AJ, Dupuy C, Schlumberger M, Bidart JM.

Thyroid. 2013 Jul 3. doi: 10.1089/thy.2012.0224. Epub 2013 Jul 3. Retraction in: Thyroid. 2013 Sep;23(9):1183.

PMID:
23822199
3.

Regulation of gap junctions in melanoma and their impact on Melan-A/MART-1-specific CD8⁺ T lymphocyte emergence.

Benlalam H, Carré T, Jalil A, Noman Z, Caillou B, Vielh P, Tittarelli A, Robert C, Chouaib S.

J Mol Med (Berl). 2013 Oct;91(10):1207-20. doi: 10.1007/s00109-013-1058-5. Epub 2013 Jun 7.

PMID:
23744108
4.

Is (18)F-fluorodeoxyglucose-PET/CT useful for the presurgical characterization of thyroid nodules with indeterminate fine needle aspiration cytology?

Deandreis D, Al Ghuzlan A, Auperin A, Vielh P, Caillou B, Chami L, Lumbroso J, Travagli JP, Hartl D, Baudin E, Schlumberger M, Leboulleux S.

Thyroid. 2012 Feb;22(2):165-72. doi: 10.1089/thy.2011.0255. Epub 2012 Jan 18.

PMID:
22257371
5.

ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence.

Weyemi U, Lagente-Chevallier O, Boufraqech M, Prenois F, Courtin F, Caillou B, Talbot M, Dardalhon M, Al Ghuzlan A, Bidart JM, Schlumberger M, Dupuy C.

Oncogene. 2012 Mar 1;31(9):1117-29. doi: 10.1038/onc.2011.327. Epub 2011 Aug 15.

6.

Wnt/β-catenin signaling pathway is a direct enhancer of thyroid transcription factor-1 in human papillary thyroid carcinoma cells.

Gilbert-Sirieix M, Makoukji J, Kimura S, Talbot M, Caillou B, Massaad C, Massaad-Massade L.

PLoS One. 2011;6(7):e22280. doi: 10.1371/journal.pone.0022280. Epub 2011 Jul 21.

7.

Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma.

Caillou B, Talbot M, Weyemi U, Pioche-Durieu C, Al Ghuzlan A, Bidart JM, Chouaib S, Schlumberger M, Dupuy C.

PLoS One. 2011;6(7):e22567. doi: 10.1371/journal.pone.0022567. Epub 2011 Jul 21.

8.

Identification of soluble candidate biomarkers of therapeutic response to sunitinib in medullary thyroid carcinoma in preclinical models.

Broutin S, Ameur N, Lacroix L, Robert T, Petit B, Oumata N, Talbot M, Caillou B, Schlumberger M, Dupuy C, Bidart JM.

Clin Cancer Res. 2011 Apr 1;17(7):2044-54. doi: 10.1158/1078-0432.CCR-10-2041. Epub 2011 Feb 15.

9.

Gene expression signature discriminates sporadic from post-radiotherapy-induced thyroid tumors.

Ory C, Ugolin N, Levalois C, Lacroix L, Caillou B, Bidart JM, Schlumberger M, Diallo I, de Vathaire F, Hofman P, Santini J, Malfoy B, Chevillard S.

Endocr Relat Cancer. 2011 Jan 19;18(1):193-206. doi: 10.1677/ERC-10-0205. Print 2011 Feb.

10.

Do histological, immunohistochemical, and metabolic (radioiodine and fluorodeoxyglucose uptakes) patterns of metastatic thyroid cancer correlate with patient outcome?

Deandreis D, Al Ghuzlan A, Leboulleux S, Lacroix L, Garsi JP, Talbot M, Lumbroso J, Baudin E, Caillou B, Bidart JM, Schlumberger M.

Endocr Relat Cancer. 2011 Jan 13;18(1):159-69. doi: 10.1677/ERC-10-0233. Print 2011 Feb.

PMID:
21118976
11.

Prognostic markers of survival after combined mitotane- and platinum-based chemotherapy in metastatic adrenocortical carcinoma.

Malandrino P, Al Ghuzlan A, Castaing M, Young J, Caillou B, Travagli JP, Elias D, de Baere T, Dromain C, Paci A, Chanson P, Schlumberger M, Leboulleux S, Baudin E.

Endocr Relat Cancer. 2010 Aug 16;17(3):797-807. doi: 10.1677/ERC-09-0341. Print 2010 Sep.

PMID:
20592067
12.

Adrenocortical carcinoma: is the surgical approach a risk factor of peritoneal carcinomatosis?

Leboulleux S, Deandreis D, Al Ghuzlan A, Aupérin A, Goéré D, Dromain C, Elias D, Caillou B, Travagli JP, De Baere T, Lumbroso J, Young J, Schlumberger M, Baudin E.

Eur J Endocrinol. 2010 Jun;162(6):1147-53. doi: 10.1530/EJE-09-1096. Epub 2010 Mar 26.

PMID:
20348273
13.

[Anaplastic cancer of the thyroid: an example of epithelial-mesenchymal transition].

Caillou B, Malouf G.

Ann Pathol. 2009 Nov;29 Spec No 1:S67-8. doi: 10.1016/j.annpat.2009.07.036. Epub 2009 Oct 8. Review. French. No abstract available.

PMID:
19887257
14.

Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.

Weyemi U, Caillou B, Talbot M, Ameziane-El-Hassani R, Lacroix L, Lagent-Chevallier O, Al Ghuzlan A, Roos D, Bidart JM, Virion A, Schlumberger M, Dupuy C.

Endocr Relat Cancer. 2010 Jan 29;17(1):27-37. doi: 10.1677/ERC-09-0175. Print 2010 Mar.

PMID:
19779036
15.

Aggressive inherited and sporadic medullary thyroid carcinomas display similar oncogenic pathways.

Ameur N, Lacroix L, Roucan S, Roux V, Broutin S, Talbot M, Dupuy C, Caillou B, Schlumberger M, Bidart JM.

Endocr Relat Cancer. 2009 Dec;16(4):1261-72. doi: 10.1677/ERC-08-0289. Epub 2009 Aug 12.

PMID:
19675075
16.

Expression of cell cycle biomarkers and telomere length in papillary thyroid carcinoma: a comparative study between radiation-associated and spontaneous cancers.

Achille M, Boukheris H, Caillou B, Talbot M, de Vathaire F, Sabatier L, Desmaze C, Schlumberger M, Soria JC.

Am J Clin Oncol. 2009 Feb;32(1):1-8. doi: 10.1097/COC.0b013e3181783336.

PMID:
19194115
17.

Mutational status of EGFR, BRAF, PI3KCA and JAK2 genes in endocrine tumors.

Ameur N, Lacroix L, Motte N, Baudin E, Caillou B, Ducreux M, Elias D, Chanson P, Schlumberger M, Bidart JM.

Int J Cancer. 2009 Feb 1;124(3):751-3. doi: 10.1002/ijc.23999. No abstract available.

18.

Galectin-3 for indeterminate thyroid cytology.

Al Ghuzlan A, Caillou B, Schlumberger M.

Lancet Oncol. 2008 Jun;9(6):508-10. doi: 10.1016/S1470-2045(08)70137-2. No abstract available.

PMID:
18510984
19.

Poorly differentiated follicular thyroid carcinoma: prognostic factors and relevance of histological classification.

Pulcrano M, Boukheris H, Talbot M, Caillou B, Dupuy C, Virion A, De Vathaire F, Schlumberger M.

Thyroid. 2007 Jul;17(7):639-46.

PMID:
17696834
20.

Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer.

Leboulleux S, Girard E, Rose M, Travagli JP, Sabbah N, Caillou B, Hartl DM, Lassau N, Baudin E, Schlumberger M.

J Clin Endocrinol Metab. 2007 Sep;92(9):3590-4. Epub 2007 Jul 3.

PMID:
17609301
21.

Functional characterization of human thyroid tissue with immunohistochemistry.

Faggiano A, Caillou B, Lacroix L, Talbot M, Filetti S, Bidart JM, Schlumberger M.

Thyroid. 2007 Mar;17(3):203-11.

PMID:
17381352
22.

Sodium/iodide symporter (NIS) gene expression is the limiting step for the onset of thyroid function in the human fetus.

Szinnai G, Lacroix L, Carré A, Guimiot F, Talbot M, Martinovic J, Delezoide AL, Vekemans M, Michiels S, Caillou B, Schlumberger M, Bidart JM, Polak M.

J Clin Endocrinol Metab. 2007 Jan;92(1):70-6. Epub 2006 Oct 31.

PMID:
17077129
23.

Prognostic parameters of metastatic adrenocortical carcinoma.

Assié G, Antoni G, Tissier F, Caillou B, Abiven G, Gicquel C, Leboulleux S, Travagli JP, Dromain C, Bertagna X, Bertherat J, Schlumberger M, Baudin E.

J Clin Endocrinol Metab. 2007 Jan;92(1):148-54. Epub 2006 Oct 24.

PMID:
17062775
25.

Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy.

Durante C, Haddy N, Baudin E, Leboulleux S, Hartl D, Travagli JP, Caillou B, Ricard M, Lumbroso JD, De Vathaire F, Schlumberger M.

J Clin Endocrinol Metab. 2006 Aug;91(8):2892-9. Epub 2006 May 9.

PMID:
16684830
26.

HEX, PAX-8 and TTF-1 gene expression in human thyroid tissues: a comparative analysis with other genes involved in iodide metabolism.

Lacroix L, Michiels S, Mian C, Arturi F, Caillou B, Filetti S, Schlumberger M, Bidart JM.

Clin Endocrinol (Oxf). 2006 Apr;64(4):398-404.

PMID:
16584511
27.

Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography.

Leboulleux S, Dromain C, Bonniaud G, Aupérin A, Caillou B, Lumbroso J, Sigal R, Baudin E, Schlumberger M.

J Clin Endocrinol Metab. 2006 Mar;91(3):920-5. Epub 2005 Dec 20.

PMID:
16368753
28.

Medullary thyroid carcinoma arises in the absence of prolactin signaling.

Kedzia C, Lacroix L, Ameur N, Ragot T, Kelly PA, Caillou B, Binart N.

Cancer Res. 2005 Sep 15;65(18):8497-503.

29.

Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis.

Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M.

J Clin Endocrinol Metab. 2005 Oct;90(10):5723-9. Epub 2005 Jul 19.

PMID:
16030160
30.

Radiation exposure and familial aggregation of cancers as risk factors for colorectal cancer after radioiodine treatment for thyroid carcinoma.

Rubino C, Adjadj E, Doyon F, Shamsaldin A, Abbas TM, Caillou B, Colonna M, Cecarreli C, Schvartz C, Bardet S, Langlois C, Ricard M, Schlumberger M, de Vathaire F.

Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):1084-9.

PMID:
15990012
31.

Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.

Lacroix L, Lazar V, Michiels S, Ripoche H, Dessen P, Talbot M, Caillou B, Levillain JP, Schlumberger M, Bidart JM.

Am J Pathol. 2005 Jul;167(1):223-31.

32.

Human galectin-3 immunoexpression in thyroid follicular adenomas with cell atypia.

Nucera C, Mazzon E, Caillou B, Violi MA, Moleti M, Priolo C, Sturniolo G, Puzzolo D, Cavallari V, Trimarchi F, Vermiglio F.

J Endocrinol Invest. 2005 Feb;28(2):106-12.

PMID:
15887854
33.

Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.

Bachelot A, Leboulleux S, Baudin E, Hartl DM, Caillou B, Travagli JP, Schlumberger M.

Clin Endocrinol (Oxf). 2005 Mar;62(3):376-9.

PMID:
15730423
34.

Morphological changes of follicular cell basal borders and basement membranes in benign and malignant nodular lesions of the thyroid gland: an ultrastructural study.

Cavallari V, Albiero F, Cicciarello R, Gagliardi ME, Costa G, D'Alia C, Sturniolo G, Tonante A, Labate A, Torre V, Vermiglio F, Caillou B.

Ultrastruct Pathol. 2004 Jul-Aug;28(4):199-207.

PMID:
15693631
35.

Dual oxidase2 is expressed all along the digestive tract.

El Hassani RA, Benfares N, Caillou B, Talbot M, Sabourin JC, Belotte V, Morand S, Gnidehou S, Agnandji D, Ohayon R, Kaniewski J, Noël-Hudson MS, Bidart JM, Schlumberger M, Virion A, Dupuy C.

Am J Physiol Gastrointest Liver Physiol. 2005 May;288(5):G933-42. Epub 2004 Dec 9.

36.

Combined treatment of anaplastic thyroid carcinoma with surgery, chemotherapy, and hyperfractionated accelerated external radiotherapy.

De Crevoisier R, Baudin E, Bachelot A, Leboulleux S, Travagli JP, Caillou B, Schlumberger M.

Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1137-43.

PMID:
15519785
37.

PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.

Lacroix L, Mian C, Barrier T, Talbot M, Caillou B, Schlumberger M, Bidart JM.

Eur J Endocrinol. 2004 Sep;151(3):367-74.

PMID:
15362967
38.

Iodotyrosine dehalogenase 1 (DEHAL1) is a transmembrane protein involved in the recycling of iodide close to the thyroglobulin iodination site.

Gnidehou S, Caillou B, Talbot M, Ohayon R, Kaniewski J, Noël-Hudson MS, Morand S, Agnangji D, Sezan A, Courtin F, Virion A, Dupuy C.

FASEB J. 2004 Oct;18(13):1574-6. Epub 2004 Aug 2.

PMID:
15289438
39.

Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters.

Lacroix L, Pourcher T, Magnon C, Bellon N, Talbot M, Intaraphairot T, Caillou B, Schlumberger M, Bidart JM.

J Clin Endocrinol Metab. 2004 Mar;89(3):1423-8.

PMID:
15001644
40.

[Cervical cystic lymph-node metastases from epidermoid carcinoma].

Marandas P, Germain MA, Casiraghi O, Garnault M, Luboinski B, Caillou B, Cachin Y.

Bull Acad Natl Med. 2003;187(6):1117-27; discussion 1127-8. Review. French.

PMID:
14978872
41.

Age-dependent variation of follicular size and expression of iodine transporters in human thyroid tissue.

Faggiano A, Coulot J, Bellon N, Talbot M, Caillou B, Ricard M, Bidart JM, Schlumberger M.

J Nucl Med. 2004 Feb;45(2):232-7.

42.

Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.

Scollo C, Baudin E, Travagli JP, Caillou B, Bellon N, Leboulleux S, Schlumberger M.

J Clin Endocrinol Metab. 2003 May;88(5):2070-5.

PMID:
12727956
43.

Differential expression of galectin 3 in solid cell nests and C cells of human thyroid.

Faggiano A, Talbot M, Baudin E, Bidart JM, Schlumberger M, Caillou B.

J Clin Pathol. 2003 Feb;56(2):142-3.

44.

Differential expression of galectin-3 in medullary thyroid carcinoma and C-cell hyperplasia.

Faggiano A, Talbot M, Lacroix L, Bidart JM, Baudin E, Schlumberger M, Caillou B.

Clin Endocrinol (Oxf). 2002 Dec;57(6):813-9.

PMID:
12460332
45.

Relationship between tumor burden and serum thyroglobulin level in patients with papillary and follicular thyroid carcinoma.

Bachelot A, Cailleux AF, Klain M, Baudin E, Ricard M, Bellon N, Caillou B, Travagli JP, Schlumberger M.

Thyroid. 2002 Aug;12(8):707-11.

PMID:
12225639
46.

Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes.

Rodriguez AM, Perron B, Lacroix L, Caillou B, Leblanc G, Schlumberger M, Bidart JM, Pourcher T.

J Clin Endocrinol Metab. 2002 Jul;87(7):3500-3.

PMID:
12107270
47.

Association of RET codon 691 polymorphism in radiation-induced human thyroid tumours with C-cell hyperplasia in peritumoural tissue.

Bounacer A, Du Villard JA, Wicker R, Caillou B, Schlumberger M, Sarasin A, Suárez HG.

Br J Cancer. 2002 Jun 17;86(12):1929-36.

48.

Characteristics of follicular cell-derived thyroid carcinomas occurring after external radiation exposure: results of a case control study nested in a cohort.

Rubino C, Cailleux AF, Abbas M, Diallo I, Shamsaldin A, Caillou B, De Vathaire F, Schlumberger M.

Thyroid. 2002 Apr;12(4):299-304.

PMID:
12034054
49.

Regulation by human chorionic gonadotropin of sodium/iodide symporter gene expression in the JAr human choriocarcinoma cell line.

Arturi F, Lacroix L, Presta I, Scarpelli D, Caillou B, Schlumberger M, Russo D, Bidart JM, Filetti S.

Endocrinology. 2002 Jun;143(6):2216-20.

PMID:
12021185
50.

Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804.

Lombardo F, Baudin E, Chiefari E, Arturi F, Bardet S, Caillou B, Conte C, Dallapiccola B, Giuffrida D, Bidart JM, Schlumberger M, Filetti S.

J Clin Endocrinol Metab. 2002 Apr;87(4):1674-80.

PMID:
11932300

Supplemental Content

Loading ...
Support Center